Literature DB >> 19507000

Analgesic targets: today and tomorrow.

Ian W Rodger1.   

Abstract

Pain is recognized as a multifactorial sensory experience that is wholly unpleasant. It can vary in intensity from mild to severe and its duration can be anything from transient to persistent. Today we know so much more about the peripheral nociceptor as the primary detection apparatus for painful stimuli. We also understand in far greater detail the neurochemical mechanisms that occur at the level of the spinal cord and the complex interplay that exists between excitatory and inhibitory neural pathways. As a consequence of the assembly of this new body of evidence there are clear pointers that direct our attention to receptors, signaling pathways, enzymes and ion channels that all have the potential to be targets for novel, effective analgesics. The purpose of this review is to highlight some of the knowledge that has been assembled on this subject in recent years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507000     DOI: 10.1007/s10787-009-0006-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  64 in total

Review 1.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 2.  Molecular mechanisms of nociception.

Authors:  D Julius; A I Basbaum
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans.

Authors:  D McGuire; S Bowersox; J D Fellmann; R R Luther
Journal:  J Cardiovasc Pharmacol       Date:  1997-09       Impact factor: 3.105

Review 5.  Therapeutic potential of cannabinoid receptor agonists as analgesic agents.

Authors:  Alyson Fox; Stuart Bevan
Journal:  Expert Opin Investig Drugs       Date:  2005-06       Impact factor: 6.206

6.  Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.

Authors:  M Félétou; M Germain; C Thurieau; J L Fauchère; E Canet
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

Review 7.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

Review 8.  Resurgence of sodium channel research.

Authors:  A L Goldin
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

9.  Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice.

Authors:  D A Cockayne; S G Hamilton; Q M Zhu; P M Dunn; Y Zhong; S Novakovic; A B Malmberg; G Cain; A Berson; L Kassotakis; L Hedley; W G Lachnit; G Burnstock; S B McMahon; A P Ford
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

10.  GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

Authors:  Robert J Harvey; Ulrike B Depner; Heinz Wässle; Seifollah Ahmadi; Cornelia Heindl; Heiko Reinold; Trevor G Smart; Kirsten Harvey; Burkhard Schütz; Osama M Abo-Salem; Andreas Zimmer; Pierrick Poisbeau; Hans Welzl; David P Wolfer; Heinrich Betz; Hanns Ulrich Zeilhofer; Ulrike Müller
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

View more
  6 in total

Review 1.  Genetic variability of pain perception and treatment--clinical pharmacological implications.

Authors:  Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2011-02-23       Impact factor: 2.953

Review 2.  Pharmacogenetics of new analgesics.

Authors:  Jörn Lötsch; Gerd Geisslinger
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 3.  Pharmacology of intra-articular triamcinolone.

Authors:  Justin Scherer; K D Rainsford; Colin A Kean; Walter F Kean
Journal:  Inflammopharmacology       Date:  2014-05-14       Impact factor: 4.473

4.  The TRPA1 Channel Mediates Mechanical Allodynia and Thermal Hyperalgesia in a Rat Bone Cancer Pain Model.

Authors:  Qiangwei Liu; Long Feng; Xiujing Han; Weidong Zhang; Hong Zhang; Longhe Xu
Journal:  Front Pain Res (Lausanne)       Date:  2021-03-22

5.  The musculoskeletal abnormalities of the Similaun Iceman ("ÖTZI"): clues to chronic pain and possible treatments.

Authors:  Walter F Kean; Shannon Tocchio; Mary Kean; K D Rainsford
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

6.  Possible mechanisms involved in the anti-nociceptive effects of hydro-ethanolic leaf extract of Ziziphus abyssinica.

Authors:  Eric Boakye-Gyasi; Isaac Tabiri Henneh; Wonder Kofi Mensah Abotsi; Elvis Ofori Ameyaw; Eric Woode
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.